|
|
microtubule polymerization or depolymerization
|
GO:0031109 |
26 |
0.176
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.071
|
Human |
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.056
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.055
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.053
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.053
|
|
|
|
microtubule polymerization
|
GO:0046785 |
12 |
0.053
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.051
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.049
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.047
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.046
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.046
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.046
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.045
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.044
|
Human |
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.044
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.044
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.043
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.043
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.043
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.043
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.042
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.041
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.041
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.041
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.039
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.039
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.037
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.036
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.036
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.035
|
|
|
|
spindle assembly involved in meiosis
|
GO:0090306 |
4 |
0.035
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.035
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.034
|
Human |
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.033
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.033
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.033
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.033
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.033
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.033
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.032
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.032
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.032
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.031
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.031
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.031
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.031
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.030
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.030
|
Human |
|
|
cell division
|
GO:0051301 |
120 |
0.030
|
|
|
|
positive regulation of nuclear division
|
GO:0051785 |
27 |
0.029
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.029
|
Human |
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.029
|
|
|
|
microtubule nucleation
|
GO:0007020 |
2 |
0.028
|
|
|
|
regulation of exit from mitosis
|
GO:0007096 |
1 |
0.027
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.027
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.026
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.025
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.025
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.025
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.024
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.024
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.024
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.024
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.024
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.024
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.024
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.024
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.024
|
Human |
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.024
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.024
|
Human |
|
|
t cell activation
|
GO:0042110 |
289 |
0.024
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.023
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.023
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.023
|
Human |
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.023
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.022
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.022
|
Human |
|
|
mapk cascade
|
GO:0000165 |
281 |
0.022
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.021
|
Human |
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.021
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.021
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.021
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.021
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.021
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.021
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.021
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.021
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.020
|
Human |
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.020
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.020
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.020
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.020
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.020
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.020
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.020
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.020
|
|
|
|
microtubule cytoskeleton organization involved in mitosis
|
GO:1902850 |
4 |
0.020
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.020
|
Human |
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.019
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.019
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.019
|
|
|
|
spindle assembly involved in mitosis
|
GO:0090307 |
4 |
0.019
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.019
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.019
|
Human |
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.019
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.019
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.019
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.018
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.018
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.018
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.018
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.018
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.018
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.018
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.018
|
Human |
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.018
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.018
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.018
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.018
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.017
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.017
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.017
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.017
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.017
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.017
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.017
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.017
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.017
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.017
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.017
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.017
|
|
|
|
regulation of microtubule based process
|
GO:0032886 |
52 |
0.017
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.017
|
Human |
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.017
|
Human |
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.017
|
|
|
|
establishment of meiotic spindle orientation
|
GO:0051296 |
1 |
0.016
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.016
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.016
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.016
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.016
|
Human |
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.016
|
Human |
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.016
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.016
|
|
|
|
metaphase plate congression
|
GO:0051310 |
2 |
0.016
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.016
|
Human |
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.016
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.016
|
Human |
|
|
male meiosis
|
GO:0007140 |
37 |
0.016
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.016
|
Human |
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.016
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.015
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.015
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.015
|
Human |
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.015
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.015
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.015
|
Human |
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.015
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.015
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.015
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.015
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.015
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.015
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.015
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.015
|
Human |
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.015
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.015
|
Human |
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.015
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.015
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.014
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.014
|
Human |
|
|
inflammatory response
|
GO:0006954 |
244 |
0.014
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.014
|
Human |
|
|
germ cell development
|
GO:0007281 |
185 |
0.014
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.014
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.014
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.014
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.014
|
|
|
|
negative regulation of cytoskeleton organization
|
GO:0051494 |
36 |
0.014
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.014
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.014
|
Human |
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.014
|
Human |
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.014
|
Human |
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.014
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.014
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.014
|
Human |
|
|
regulation of mitotic sister chromatid segregation
|
GO:0033047 |
12 |
0.014
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.014
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.014
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.014
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.014
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.014
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.014
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.014
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.013
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.013
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.013
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.013
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.013
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.013
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.013
|
|
|
|
protein depolymerization
|
GO:0051261 |
34 |
0.013
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.013
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.013
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.013
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.013
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.013
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.013
|
Human |
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.013
|
Human |
|
|
fertilization
|
GO:0009566 |
127 |
0.013
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.013
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.013
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.013
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.013
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.012
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.012
|
Human |
|
|
actin filament organization
|
GO:0007015 |
113 |
0.012
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.012
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.012
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.012
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.012
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.012
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.012
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.012
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.012
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.012
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.012
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.012
|
Human |
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.012
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.012
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.012
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.012
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.012
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.012
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.012
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.012
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.012
|
Human |
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.012
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.012
|
|
|
|
double strand break repair
|
GO:0006302 |
48 |
0.012
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.012
|
Human |
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.012
|
Human |
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.012
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.011
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.011
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.011
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.011
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.011
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.011
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.011
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.011
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.011
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.011
|
|
|
|
negative regulation of cell size
|
GO:0045792 |
3 |
0.011
|
|
|
|
regulation of microtubule cytoskeleton organization
|
GO:0070507 |
37 |
0.011
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.011
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.011
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.011
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.011
|
Human |
|
|
action potential
|
GO:0001508 |
78 |
0.011
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.011
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.011
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.011
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.011
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.011
|
|
|
|
cellular protein complex disassembly
|
GO:0043624 |
36 |
0.011
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.011
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.011
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.011
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.011
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.011
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.011
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.011
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.011
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.011
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.011
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.011
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.011
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.011
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.011
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.011
|
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
43 |
0.011
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.010
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.010
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.010
|
|
|
|
cell cycle switching
|
GO:0060184 |
1 |
0.010
|
|
|
|
establishment of spindle orientation
|
GO:0051294 |
15 |
0.010
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.010
|
|
|
|
protein complex disassembly
|
GO:0043241 |
40 |
0.010
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.010
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.010
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.010
|
Human |
|
|
kidney development
|
GO:0001822 |
213 |
0.010
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.010
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.010
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.010
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.010
|
Human |
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.010
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.010
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.010
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.010
|
|
|
|
spindle localization
|
GO:0051653 |
22 |
0.010
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.010
|
|
|
|
mitotic chromosome condensation
|
GO:0007076 |
1 |
0.010
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.010
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.010
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.010
|
|
|
|
negative regulation of microtubule polymerization or depolymerization
|
GO:0031111 |
15 |
0.010
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.010
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.010
|
|